With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

Amidst the abundance of news about Artificial Intelligence (AI) and its applications, a rather interesting development has taken place in the latest advancements in drug discovery research. Recent funding to Atomic AI, a San Franciscan based company, has opened up a new frontier in the search for treatments and cures to diseases. By harnessing the… Continue reading With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

Exit mobile version